CA Stock MarketDetailed Quotes

MJRX Global Health Clinics Ltd

Watchlist
  • 0.040
  • 0.0000.00%
15min DelayTrading Aug 8 14:15 ET
375.69KMarket Cap-363P/E (TTM)

Global Health Clinics Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
66.26%-90.1K
-5.24%-87.78K
70.90%-152.25K
32.17%-1.01M
-11.49%-136.17K
-83.26%-267.08K
78.02%-83.41K
37.83%-523.18K
-80.29%-1.49M
65.67%-122.14K
Net income from continuing operations
48.47%-247.58K
-9.54%-258.46K
60.72%-239.01K
-18.70%-1.63M
-14.64%-300.31K
-97.78%-480.46K
51.55%-235.96K
-61.25%-608.46K
83.85%-1.37M
96.30%-261.95K
Operating gains losses
----
----
----
----
----
----
----
---2.75K
----
----
Depreciation and amortization
-23.77%93
-23.77%93
-23.77%93
-24.69%488
-24.69%122
-24.69%122
-24.69%122
-24.69%122
-99.49%648
-99.55%162
Asset impairment expenditure
----
----
----
--0
----
----
----
----
-99.95%1.26K
--0
Other non cashItems
109.96%31.99K
298.57%30.18K
254.33%29.49K
325.82%52.06K
184.85%20.93K
411.76%15.24K
663.41%7.57K
814.62%8.32K
263.73%12.23K
731.00%7.35K
Change In working capital
-36.67%125.4K
-1.19%140.4K
-28.16%57.17K
520.71%562.82K
8.16%143.1K
110.57%198.03K
33.60%142.1K
117.06%79.59K
-128.45%-133.78K
12.13%132.31K
-Change in receivables
-81.74%4.32K
3,753.85%2.38K
54.12%-3.86K
1,043.79%12.61K
-372.32%-2.59K
393.46%23.67K
99.07%-65
-165.79%-8.4K
-100.78%-1.34K
109.23%950
-Change in prepaid assets
--0
-98.58%133
-97.86%200
-41.60%41.85K
174.31%20.2K
-81.47%2.98K
-96.28%9.34K
105.55%9.34K
189.42%71.66K
66.51%-27.18K
-Change in payables and accrued expense
-30.23%119.5K
-2.00%135.83K
-22.70%64.63K
365.14%518.7K
-24.42%125.24K
97.36%171.27K
197.75%138.59K
127.29%83.6K
-148.49%-195.63K
-22.45%165.72K
-Change in other working capital
1,189.43%1.59K
135.88%2.07K
23.26%-3.8K
-22.17%-10.35K
103.36%241
117.04%123
-245.23%-5.76K
-9.11%-4.95K
64.26%-8.47K
-68.83%-7.18K
Cash from discontinued investing activities
Operating cash flow
66.26%-90.1K
-5.24%-87.78K
70.90%-152.25K
32.17%-1.01M
-11.49%-136.17K
-83.26%-267.08K
78.02%-83.41K
37.83%-523.18K
-80.29%-1.49M
65.67%-122.14K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-70.00%87K
-51.60%48.4K
0
-52.43%727.48K
-52.22%291.48K
108.23%290K
233.33%100K
-93.87%46K
100.37%1.53M
610K
Net issuance payments of debt
-70.00%87K
-51.60%48.4K
--0
160.49%727.48K
164.98%291.48K
108.23%290K
233.33%100K
--46K
--279.27K
--110K
Net common stock issuance
----
----
----
--0
----
----
----
----
63.78%1.25M
--500K
Cash from discontinued financing activities
Financing cash flow
-70.00%87K
-51.60%48.4K
--0
-52.43%727.48K
-52.22%291.48K
108.23%290K
233.33%100K
-93.87%46K
100.37%1.53M
--610K
Net cash flow
Beginning cash position
-37.10%22.7K
218.25%62.09K
-56.85%214.34K
8.86%496.69K
568.65%59.02K
136.05%36.1K
-94.65%19.51K
8.86%496.69K
407.75%456.26K
-98.91%8.83K
Current changes in cash
-113.52%-3.1K
-337.39%-39.38K
68.09%-152.25K
-798.27%-282.35K
-68.16%155.32K
454.60%22.93K
104.75%16.59K
-421.47%-477.18K
-88.96%40.44K
237.14%487.87K
End cash Position
-66.79%19.6K
-37.10%22.7K
218.25%62.09K
-56.85%214.34K
-56.85%214.34K
568.65%59.02K
136.05%36.1K
-94.65%19.51K
8.86%496.69K
8.86%496.69K
Free cash from
66.26%-90.1K
-5.24%-87.78K
70.90%-152.25K
32.17%-1.01M
-11.49%-136.17K
-83.26%-267.08K
78.02%-83.41K
37.83%-523.18K
-80.29%-1.49M
65.67%-122.14K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 66.26%-90.1K-5.24%-87.78K70.90%-152.25K32.17%-1.01M-11.49%-136.17K-83.26%-267.08K78.02%-83.41K37.83%-523.18K-80.29%-1.49M65.67%-122.14K
Net income from continuing operations 48.47%-247.58K-9.54%-258.46K60.72%-239.01K-18.70%-1.63M-14.64%-300.31K-97.78%-480.46K51.55%-235.96K-61.25%-608.46K83.85%-1.37M96.30%-261.95K
Operating gains losses -------------------------------2.75K--------
Depreciation and amortization -23.77%93-23.77%93-23.77%93-24.69%488-24.69%122-24.69%122-24.69%122-24.69%122-99.49%648-99.55%162
Asset impairment expenditure --------------0-----------------99.95%1.26K--0
Other non cashItems 109.96%31.99K298.57%30.18K254.33%29.49K325.82%52.06K184.85%20.93K411.76%15.24K663.41%7.57K814.62%8.32K263.73%12.23K731.00%7.35K
Change In working capital -36.67%125.4K-1.19%140.4K-28.16%57.17K520.71%562.82K8.16%143.1K110.57%198.03K33.60%142.1K117.06%79.59K-128.45%-133.78K12.13%132.31K
-Change in receivables -81.74%4.32K3,753.85%2.38K54.12%-3.86K1,043.79%12.61K-372.32%-2.59K393.46%23.67K99.07%-65-165.79%-8.4K-100.78%-1.34K109.23%950
-Change in prepaid assets --0-98.58%133-97.86%200-41.60%41.85K174.31%20.2K-81.47%2.98K-96.28%9.34K105.55%9.34K189.42%71.66K66.51%-27.18K
-Change in payables and accrued expense -30.23%119.5K-2.00%135.83K-22.70%64.63K365.14%518.7K-24.42%125.24K97.36%171.27K197.75%138.59K127.29%83.6K-148.49%-195.63K-22.45%165.72K
-Change in other working capital 1,189.43%1.59K135.88%2.07K23.26%-3.8K-22.17%-10.35K103.36%241117.04%123-245.23%-5.76K-9.11%-4.95K64.26%-8.47K-68.83%-7.18K
Cash from discontinued investing activities
Operating cash flow 66.26%-90.1K-5.24%-87.78K70.90%-152.25K32.17%-1.01M-11.49%-136.17K-83.26%-267.08K78.02%-83.41K37.83%-523.18K-80.29%-1.49M65.67%-122.14K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -70.00%87K-51.60%48.4K0-52.43%727.48K-52.22%291.48K108.23%290K233.33%100K-93.87%46K100.37%1.53M610K
Net issuance payments of debt -70.00%87K-51.60%48.4K--0160.49%727.48K164.98%291.48K108.23%290K233.33%100K--46K--279.27K--110K
Net common stock issuance --------------0----------------63.78%1.25M--500K
Cash from discontinued financing activities
Financing cash flow -70.00%87K-51.60%48.4K--0-52.43%727.48K-52.22%291.48K108.23%290K233.33%100K-93.87%46K100.37%1.53M--610K
Net cash flow
Beginning cash position -37.10%22.7K218.25%62.09K-56.85%214.34K8.86%496.69K568.65%59.02K136.05%36.1K-94.65%19.51K8.86%496.69K407.75%456.26K-98.91%8.83K
Current changes in cash -113.52%-3.1K-337.39%-39.38K68.09%-152.25K-798.27%-282.35K-68.16%155.32K454.60%22.93K104.75%16.59K-421.47%-477.18K-88.96%40.44K237.14%487.87K
End cash Position -66.79%19.6K-37.10%22.7K218.25%62.09K-56.85%214.34K-56.85%214.34K568.65%59.02K136.05%36.1K-94.65%19.51K8.86%496.69K8.86%496.69K
Free cash from 66.26%-90.1K-5.24%-87.78K70.90%-152.25K32.17%-1.01M-11.49%-136.17K-83.26%-267.08K78.02%-83.41K37.83%-523.18K-80.29%-1.49M65.67%-122.14K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg